CellBall Biomedical
A Taiwan-based biotechnology company specializing in 3D cell culture and personalized cancer drug screening services.
CellBall Biomedical Co., Ltd., founded in 2025, is an innovative biotechnology company centered on 3D cell culture technologies.
Our vision
Our vision is driven by a deep understanding of cancer patients’ urgent need for precision medicine.
Traditional drug screening methods are often time-consuming and lack accuracy. Motivated by this challenge, our founding team set out to develop alternative biological models that do not rely on animal testing — breaking through conventional limitations to save valuable time for patients and enable truly personalized treatment options.
We focus on developing a 3D tumor organoid technology platform that integrates Taiwan’s local cancer database and clinical research. Our mission is to:
- provide cancer patients with precise and efficient personalized drug screening services to assist clinicians in formulating the most suitable treatment plans; and
- offer biomedical researchers a 3D cell culture service platform that more closely mimics physiological conditions.
The goal of CellBall Biomedical is to establish Taiwan as its R&D base while expanding globally, building a precision medicine platform centered on tumor organoid modeling technology. By collaborating with medical institutions, academic organizations, and pharmaceutical companies, we aim to comprehensively improve cancer treatment success rates and enhance patients’ quality of life.